Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
Cardiovascular research, 115(2): e12-e14 PMID 30668679 DOI 10.1093/cvr/cvy300
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.